Elizabeth G. Salazar, G. Wertheim, J. Biegel, W. Hwang, S. Tasian, S. Rheingold
{"title":"Mixed Phenotype Acute Leukemia with Low Hypodiploidy in a Pediatric Patient","authors":"Elizabeth G. Salazar, G. Wertheim, J. Biegel, W. Hwang, S. Tasian, S. Rheingold","doi":"10.14205/2309-3021.2015.03.01.4","DOIUrl":null,"url":null,"abstract":"We describe the case of a 16 year-old female with mixed phenotype acute leukemia B/myeloid, NOS (formerly biphenotypic leukemia) with masked hypodiploidy and somatic TP53 and CDKN2A/B deletions. She achieved morphologic remission with lymphoid-directed multi-agent chemotherapy, but experienced an early medullary relapse 11 months from initial diagnosis. Her case details the unusual finding of hypodiploidy in a patient with ambiguous lineage leukemia and highlights the complexity of therapy selection for these high-risk patients.","PeriodicalId":90229,"journal":{"name":"Journal of pediatric oncology","volume":"3 1","pages":"24 - 28"},"PeriodicalIF":0.0000,"publicationDate":"2015-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pediatric oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14205/2309-3021.2015.03.01.4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
Abstract
We describe the case of a 16 year-old female with mixed phenotype acute leukemia B/myeloid, NOS (formerly biphenotypic leukemia) with masked hypodiploidy and somatic TP53 and CDKN2A/B deletions. She achieved morphologic remission with lymphoid-directed multi-agent chemotherapy, but experienced an early medullary relapse 11 months from initial diagnosis. Her case details the unusual finding of hypodiploidy in a patient with ambiguous lineage leukemia and highlights the complexity of therapy selection for these high-risk patients.